Exploring the use of long-acting injectable HIV prevention among men who have sex with men in Baltimore
Official title: Extending the Prevention Toolbox: Exploring the Acceptability and Impact of Long-acting Injectable PrEP among MSM in Baltimore: A Pilot Study
Funded at Johns Hopkins University · NIH-11098409 · Data updated 2026-11-12
This study is looking at how well men who have sex with men in Baltimore accept and use a new long-lasting HIV prevention shot, and it aims to understand what social factors might help or hinder its use in the community.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | November 1, 2023 |
| Project end | March 21, 2025 |
| Funding year | 2025 |
| Award (this year) | $48,974 |
| NIH project number | 5F31MH135787-02 |
| Project ID | NIH-11098409 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men who have sex with men living in Baltimore, particularly those at high risk for HIV.
✕Less likely to help
Patients who do not identify as men who have sex with men or those not residing in Baltimore may not benefit from this research.
What this research studies
This research investigates the acceptability and impact of long-acting injectable pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Baltimore, where HIV incidence is notably high. The study aims to understand how social and structural factors influence the uptake of this innovative prevention method. By engaging with the community, the research will gather insights on perceptions and behaviors related to long-acting PrEP, particularly in high-risk populations. Participants will be asked about their experiences and attitudes towards this new form of HIV prevention, which could lead to improved strategies for increasing its use.
Why it matters
Potential benefit: If successful, this research could enhance HIV prevention strategies and reduce the incidence of HIV among high-risk populations.
How similar studies have gone: Previous studies have shown promise in exploring the acceptability of long-acting PrEP, but this specific approach in high-risk communities is relatively novel.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Dhir, Amit "Mickey" — Johns Hopkins University
- Study coordinator: Dhir, Amit "Mickey"
Related research
Other NIH-funded projects on the same topics.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
TB PrEP: Bringing HIV prevention to households affected by TB in Uganda
Aims to help people in households with TB in Uganda access HIV PrEP as part of a combined prevention approach.
-
CARES: A practical program to help adolescent girls and young women use PrEP in Africa
A program called CARES helps young women in South Africa and Zimbabwe use different PrEP options better, with counseling, reminders, and options for support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.